The loss of PTEN contributed to resistance to immunotherapy in melanoma, mainly by activating the PI3K pathway and decreasing the level of CD8 T cells in tumors through the secretion of immunosuppresive cytokines as well as by inhibiting autophagy [80]. This evidence concerns the gene CD8A and melanoma.